THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation CONTINUED ACCESS
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 148 participants.
Also called NCT01639495
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 148 participants
- Sponsor
- Registry
-
NCT01639495
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01639495. Allocation not applicable; no masking; primary purpose treatment. Start 2012-07-01 (actual); primary completion 2014-06-01 (actual). Results posted on 2018-05-15.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation CONTINUED ACCESS
- Condition
- Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
- Intervention (Device)
- THERMOCOOL® SMARTTOUCH™ Catheter
- Lead sponsor
- Biosense Webster, Inc.
Record details
- Record id
cardio:ct-nct01639495- Content hash
2d8b3e06c8ab9d07e61d92b857de4f936185b6d578bbe744a8f5505b88165442